Back to Search Start Over

Human peripheral CD4+ Vδ1+ γδT cells can develop into αβT cells.

Authors :
Ziegler, Hendrik
Welker, Christian
Sterk, Marco
Haarer, Jan
Rammensee, Hans-Georg
Handgretinger, Rupert
Schilbach, Karin
Schönbach, Christian
Kaye, Jonathan
Source :
Frontiers in Immunology; Dec2014, Vol. 5, p1-23, 23p
Publication Year :
2014

Abstract

The lifelong generation of αβT cells enables us to continuously build immunity against pathogens and malignancies despite the loss of thymic function with age. Homeostatic proliferation of post-thymic naïve and memory T cells and their transition into effector and long-lived memory cells balance the decreasing output of naïveT cells, and recent research suggests that also αβT-cell development independent from the thymus may occur. However, the sites and mechanisms of extrathymic T-cell development are not yet understood in detail. γδT cells represent a small fraction of the overall T-cell pool, and are endowed with tremendous phenotypic and functional plasticity. γδT cells that express the Vδ1 gene segment are a minor population in human peripheral blood but predominate in epithelial (and inflamed) tissues. Here, we characterize a CD4<superscript>+</superscript> peripheral Vδ1<superscript>+</superscript> γδT-cell subpopulation that expresses stem-cell and progenitor markers and is able to develop into functional abT cells ex vivo in a simple culture system and in vivo. The route taken by this process resembles thymic T-cell development. However, it involves the re-organization of the Vδ1<superscript>+</superscript> γδTCR into the abTCR as a consequence ofTCR-γ chain downregulation and the expression of surfaceVδ1<superscript>+</superscript>Vβ<superscript>+</superscript>TCR components, whichwe believe function as surrogate pre-TCR.This transdifferentiation process is readily detectable in vivo in inflamed tissue. Our study provides a conceptual framework for extrathymicT-cell development and opens up a new vista in immunology that requires adaptive immune responses in infection, autoimmunity, and cancer to be reconsidered. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16643224
Volume :
5
Database :
Complementary Index
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
101665268
Full Text :
https://doi.org/10.3389/fimmu.2014.00645